Inhibition of SHP2 as an approach to block RAS-driven cancers

YT Chou, TG Bivona - Advances in Cancer Research, 2022 - Elsevier
The non-receptor protein tyrosine phosphatase SHP2 (encoded by PTPN11) is a critical
component of RAS/MAPK signaling by acting upstream of RAS to promote oncogenic …
被引用次数：12 相关文章

Inhibition of SHP2 as an approach to block RAS-driven cancers

YT Chou, TG Bivona - RAS: Past, Present, and Future, 2022 - books.google.com
Inhibition of SHP2 as an approach to block RAS-driven cancers Page 220 CHAPTER SEVEN
Inhibition of SHP2 as an approach to block RAS-driven cancers Yu-Ting Chou and Trever G …

Inhibition of SHP2 as an approach to block RAS-driven cancers

YT Chou, TG Bivona - Advances in cancer research, 2022 - pubmed.ncbi.nlm.nih.gov
The non-receptor protein tyrosine phosphatase SHP2 (encoded by PTPN11) is a critical
component of RAS/MAPK signaling by acting upstream of RAS to promote oncogenic …

Inhibition of SHP2 as an approach to block RAS-driven cancers.

YT Chou, TG Bivona - Advances in Cancer Research, 2021 - europepmc.org
The non-receptor protein tyrosine phosphatase SHP2 (encoded by PTPN11) is a critical
component of RAS/MAPK signaling by acting upstream of RAS to promote oncogenic …